Some of the best minds on Wall Street lent a peek into their portfolios at Monday’s Ira Sohn Investment Conference. Here are some of their recent plays.
David Einhorn
The Greenlight Capital founder is long AerCap Holdings N.V. AER as it trades at a 50-percent discount to GATX Corporation GATX. Einhorn is short the latter.
“Neither has consumer-facing businesses, and both have terrible news. AerCap operates in a growing industry with a favorable outlook,” he said. “We think the market has it wrong.”
Ryan Heslop
Firefly Value Partners is short Community Health Systems CYH and forecasts a bankruptcy filing within the next few years. By Heslop’s assessment, it’s taken on too much debt after an “acquisition binge.”
Looking to gain an edge in your trading and investing? Look no further than the Benzinga Trading & Investing Summit this June 20 in NYC!
Laura Deming
The Longevity Fund partner is long Unity Biotechnology Inc UBX, Precision BioSciences Inc DTIL, ALX Oncology, Navitor Pharmaceuticals and Metacrine.
Larry Robbins
The Glenview Capital Management CEO is short 3M Co MMM, Chemours Co CC and big pharma.
Robbins recommends buying hospitals, HCA Healthcare Inc HCA and HMO-related companies, such as Humana Inc HUM, UnitedHealth Group Inc UNH, Tenet Healthcare Corp THC and his group favorite, Cigna Corp CI.
Christopher Hansen
The manager of Valiant Capital is long Zillow Group Inc Class A ZG for its high traffic volume and competitive position in real estate.
“We think there’s another big stair-step for this business coming,” Hansen said.
Bihua Chen
Cormorant Asset Management is long Reata Pharmaceuticals Inc RETA for the “striking efficacy” of Bardoxolone.
“I think its safety profile is real and sustainable,” founder Chen said.
Related Links:
Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
Top Ideas From The 2018 Sohn Conference: Box, Facebook, Palo Alto And More
Photo by Acroterion/Wikimedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
